Back to search
FDAFDA · Food and drugs·Recall number D-0910-2023

allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC 11673-617-39), c)70-count cartons (NDC 11673-617-01), and d)150-count cartons (11673-617-47), Distributed by: Target Corporation, Minneapolis, MN 55403.

Published July 19, 2023 · Recall initiated: February 9, 2023

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
L. Perrigo Company
Distributor
Nationwide within the USA
Lot
Lot #: a) 2HE2032, 2JE1882, 2JE2185 Exp. Date 01/24; b) 2DR0464, 2ER0410, Exp. Date 12/23; 2ER0286, 2ER0411, Exp. Date 01/24 c) 2DR0467, 2DR0468, 2DR0469, 2ER0288, Exp. Date 12/23 d) 2ER0414, Exp. Date 01/24, 2GR0333, Exp. Date 02/24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card